vs

Side-by-side financial comparison of Fat Brands, Inc (FAT) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $140.0M, roughly 1.2× Fat Brands, Inc). Fat Brands, Inc runs the higher net margin — -41.6% vs -82.0%, a 40.4% gap on every dollar of revenue. On growth, Fat Brands, Inc posted the faster year-over-year revenue change (-2.3% vs -22.7%). Fat Brands, Inc produced more free cash flow last quarter ($-16.9M vs $-36.6M). Over the past eight quarters, Fat Brands, Inc's revenue compounded faster (-6.1% CAGR vs -11.5%).

FAT Brands Inc. is an American multi-brand restaurant and sports bar franchise operator headquartered in Beverly Hills, California.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

FAT vs PTCT — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.2× larger
PTCT
$164.7M
$140.0M
FAT
Growing faster (revenue YoY)
FAT
FAT
+20.4% gap
FAT
-2.3%
-22.7%
PTCT
Higher net margin
FAT
FAT
40.4% more per $
FAT
-41.6%
-82.0%
PTCT
More free cash flow
FAT
FAT
$19.8M more FCF
FAT
$-16.9M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
FAT
FAT
Annualised
FAT
-6.1%
-11.5%
PTCT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
FAT
FAT
PTCT
PTCT
Revenue
$140.0M
$164.7M
Net Profit
$-58.2M
$-135.0M
Gross Margin
Operating Margin
-12.4%
-43.3%
Net Margin
-41.6%
-82.0%
Revenue YoY
-2.3%
-22.7%
Net Profit YoY
-30.1%
-104.8%
EPS (diluted)
$-3.39
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FAT
FAT
PTCT
PTCT
Q4 25
$164.7M
Q3 25
$140.0M
$211.0M
Q2 25
$146.8M
$178.9M
Q1 25
$142.0M
$1.2B
Q4 24
$145.3M
$213.2M
Q3 24
$143.4M
$196.8M
Q2 24
$152.0M
$186.7M
Q1 24
$152.0M
$210.1M
Net Profit
FAT
FAT
PTCT
PTCT
Q4 25
$-135.0M
Q3 25
$-58.2M
$15.9M
Q2 25
$-54.2M
$-64.8M
Q1 25
$-46.0M
$866.6M
Q4 24
$-67.4M
$-65.9M
Q3 24
$-44.8M
$-106.7M
Q2 24
$-39.4M
$-99.2M
Q1 24
$-38.3M
$-91.6M
Operating Margin
FAT
FAT
PTCT
PTCT
Q4 25
-43.3%
Q3 25
-12.4%
1.4%
Q2 25
-10.6%
-19.5%
Q1 25
-6.0%
82.5%
Q4 24
-27.1%
-76.2%
Q3 24
-6.2%
-27.7%
Q2 24
-1.8%
-21.5%
Q1 24
-0.9%
-21.6%
Net Margin
FAT
FAT
PTCT
PTCT
Q4 25
-82.0%
Q3 25
-41.6%
7.5%
Q2 25
-36.9%
-36.3%
Q1 25
-32.4%
73.7%
Q4 24
-46.4%
-30.9%
Q3 24
-31.2%
-54.2%
Q2 24
-25.9%
-53.1%
Q1 24
-25.2%
-43.6%
EPS (diluted)
FAT
FAT
PTCT
PTCT
Q4 25
$-1.63
Q3 25
$-3.39
$0.20
Q2 25
$-3.17
$-0.83
Q1 25
$-2.73
$10.04
Q4 24
$-4.06
$-0.85
Q3 24
$-2.74
$-1.39
Q2 24
$-2.43
$-1.29
Q1 24
$-2.37
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FAT
FAT
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$1.9B
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$-585.8M
$-205.3M
Total Assets
$1.2B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FAT
FAT
PTCT
PTCT
Q4 25
$1.9B
Q3 25
$1.7B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$1.1B
Q3 24
$1.0B
Q2 24
$1.1B
Q1 24
$884.8M
Total Debt
FAT
FAT
PTCT
PTCT
Q4 25
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.2B
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
FAT
FAT
PTCT
PTCT
Q4 25
$-205.3M
Q3 25
$-585.8M
$-155.8M
Q2 25
$-536.5M
$-206.5M
Q1 25
$-493.9M
$-185.8M
Q4 24
$-455.7M
$-1.1B
Q3 24
$-386.1M
$-1.1B
Q2 24
$-338.6M
$-980.2M
Q1 24
$-296.8M
$-893.9M
Total Assets
FAT
FAT
PTCT
PTCT
Q4 25
$2.9B
Q3 25
$1.2B
$2.6B
Q2 25
$1.2B
$2.6B
Q1 25
$1.3B
$2.7B
Q4 24
$1.3B
$1.7B
Q3 24
$1.3B
$1.8B
Q2 24
$1.4B
$1.9B
Q1 24
$1.4B
$1.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FAT
FAT
PTCT
PTCT
Operating Cash FlowLast quarter
$-14.5M
$-34.3M
Free Cash FlowOCF − Capex
$-16.9M
$-36.6M
FCF MarginFCF / Revenue
-12.1%
-22.3%
Capex IntensityCapex / Revenue
1.7%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-75.0M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FAT
FAT
PTCT
PTCT
Q4 25
$-34.3M
Q3 25
$-14.5M
$-66.3M
Q2 25
$-26.9M
$-58.3M
Q1 25
$-13.2M
$870.1M
Q4 24
$-10.4M
$-30.0M
Q3 24
$-3.2M
$-77.0M
Q2 24
$-14.2M
$-71.5M
Q1 24
$-28.4M
$70.8M
Free Cash Flow
FAT
FAT
PTCT
PTCT
Q4 25
$-36.6M
Q3 25
$-16.9M
$-69.7M
Q2 25
$-29.3M
$-59.6M
Q1 25
$-17.8M
$868.4M
Q4 24
$-11.0M
$-33.8M
Q3 24
$-11.1M
$-77.5M
Q2 24
$-24.4M
$-78.8M
Q1 24
$-32.5M
$61.2M
FCF Margin
FAT
FAT
PTCT
PTCT
Q4 25
-22.3%
Q3 25
-12.1%
-33.1%
Q2 25
-20.0%
-33.3%
Q1 25
-12.5%
73.8%
Q4 24
-7.6%
-15.8%
Q3 24
-7.7%
-39.4%
Q2 24
-16.1%
-42.2%
Q1 24
-21.4%
29.1%
Capex Intensity
FAT
FAT
PTCT
PTCT
Q4 25
1.4%
Q3 25
1.7%
1.6%
Q2 25
1.6%
0.7%
Q1 25
3.2%
0.1%
Q4 24
0.4%
1.8%
Q3 24
5.5%
0.3%
Q2 24
6.7%
4.0%
Q1 24
2.7%
4.6%
Cash Conversion
FAT
FAT
PTCT
PTCT
Q4 25
Q3 25
-4.17×
Q2 25
Q1 25
1.00×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FAT
FAT

Restaurant Sales$96.6M69%
Royalty$21.6M15%
Factory$9.6M7%
Advertising$9.1M7%
Franchisor$1.5M1%
Other$1.5M1%

PTCT
PTCT

Segment breakdown not available.

Related Comparisons